Bryan Lewis: Meet the Experts of VIRO 2025

The Global Voices in Renal Oncology (VIRO) Virtual Congress, organized by OncoDaily, will be held on September 11–12, 2025. Chaired by Dr. Rana R. McKay with co-chair Dr. Yüksel Ürün, this year’s program will feature around 50 leading experts in renal oncology from across the globe, sharing cutting-edge updates and future perspectives.

• The congress is free to attend.
• Register via the link.

Co-Chair of VIRO

Images

Name

Rana McKay Professor of Medicine and Urology at UC San Diego Health Co-leader of the GU Oncology Program at Moores Cancer Center As Co-Chair of VIRO, Dr. Rana McKay (University of California, San Diego) opened the congress with her talk on  “Future Directions: Emerging Agents and Combinations.” She emphasized the momentum in renal cell carcinoma (RCC) research, highlighting how novel immunotherapies, targeted drugs, and rational combination strategies are reshaping patient care. Dr. McKay underscored the importance of personalized, biomarker-driven approaches and global collaboration, aiming to optimize survival and quality of life worldwide.

Spotlight on Bryan Lewis

Bryan Lewis is the CEO and Co-Founder of KidneyCAN, a patient-driven movement dedicated to accelerating cures for kidney cancer through advocacy, research funding, and patient support.

At the Global Voices in Renal Oncology (VIRO) Virtual Congress 2025, Bryan will present on “KidneyCAN: Patient-Driven Movement to Accelerate Cures.” His presentation will highlight:

• The origins and mission of KidneyCAN as a grassroots organization led by patients and caregivers.
• Strategies to advocate for government and industry funding to fuel kidney cancer research.
• Efforts to foster collaboration among researchers, clinicians, patients, and policymakers.
• The vital role of patient education, support programs, and connecting patients with clinical trials.
• The importance of equity, diversity, and inclusion in advancing kidney cancer care globally.

Bryan’s advocacy has significantly influenced national research priorities, including securing millions in funding for kidney cancer research programs. He exemplifies the power of patient leadership in driving progress towards cures.

Global Voices in Renal Oncology (VIRO) 2025